PRIMARY STUDY
The Endocannabinoid System as a Window Into Microglial Biology and Its Relationship to Autism
Key Findings: A better understanding of the endocannabinoid system (ECS) and its role in Autism Spectrum Disorders (ASD) may lead to future therapeutic developments in the treatment of neurodegenerative, inflammatory, and central nervous system dysfunction.
Type of Study: Meta-analysis
Study Result: Positive
Study Location(s): United States
Year of Pub: 2019
Cannabinoids Studied: Anandamide (AEA), Fatty Acid Amide Hydrolase (FAAH), 2-Arachidonoyl Glycerol (2-AG), Monoacylglycerol Lipase (MAGL), Endocannabinoid (unspecified)
Phytocannabinoid Source: Not Applicable
Receptors Studied: CB1, CB2
